U.S. Markets open in 6 hrs 39 mins

iCAD, Inc. (ICAD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.61+0.02 (+0.44%)
At close: 4:00PM EDT
People also watch
Interactive chart
Previous Close4.59
Bid0.00 x
Ask5.23 x 2000
Day's Range4.55 - 4.83
52 Week Range2.82 - 6.49
Avg. Volume51,541
Market Cap75.49M
PE Ratio (TTM)-9.20
EPS (TTM)-0.5
Earnings DateMay 4, 2017 - May 5, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
Trade prices are not sourced from all markets
  • GlobeNewswire3 days ago

    iCAD to Participate in Two Upcoming Investor Conferences

    NASHUA, N.H., May 22, 2017-- iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced ...

  • Zacks Small Cap Research17 days ago

    ICAD: Q1: Strong Detection Offsets Weakness in NMSC Revenue

    Relative to our estimates, Q1 Detection revenue was about 20% better which more than offset a 7% miss to our Therapy number – the net result was a 9% beat to our total revenue estimate.  Detection was the clear highlight with revenue up 14% yoy – but excluding MRI revenues (i.e. Strength in Detection was attributed to 3D tomo sales in Europe – management noted 7 or 8 systems were sold in Q1 – as well as from “several very large (2D) tenders.”  Management mentioned that Q1 set a new record in terms of international CAD orders.  We note that since ordering patterns can be somewhat lumpy, we have not carried that level of revenue through to our Q2 number – but we also note that management indicated interest in 3D tomo in Europe continues to solidify and, as such, we think it is reasonable to expect that product will to continue to gain traction.

  • Thomson Reuters StreetEvents19 days ago

    Edited Transcript of ICAD earnings conference call or presentation 2-May-17 8:30pm GMT

    Q1 2017 ICAD Inc Earnings Call